CDTX
Cidara Therapeutics Inc
NASDAQ: CDTX · HEALTHCARE · BIOTECHNOLOGY
$221.38
+0.00% today
Updated 2026-01-07
Market cap
$6.96B
P/E ratio
—
P/S ratio
4,540.70x
EPS (TTM)
$-11.20
Dividend yield
—
52W range
$15 – $221
Volume
1.5M
Cidara Therapeutics Inc (CDTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $201000.00 | $24.35M | $109.97M | $106.96M | $79.03M | $79.11M | $68.98M | $60.42M | $75.33M | $47.49M | $67.03M | $214.80M |
| Cash & equivalents | $1000.00 | $185000.00 | $22.80M | $107.51M | $104.62M | $75.31M | $74.56M | $50.27M | $35.91M | $62.27M | $32.73M | $35.78M | $189.82M |
| Current assets | $1000.00 | $198000.00 | $23.01M | $108.22M | $105.40M | $77.67M | $77.13M | $65.81M | $57.19M | $71.70M | $45.09M | $60.85M | $210.74M |
| Total liabilities | $80000.00 | $1.60M | $3.25M | $6.06M | $18.78M | $19.29M | $19.97M | $31.14M | $49.71M | $53.75M | $61.92M | $75.24M | $51.49M |
| Current liabilities | $80000.00 | $116000.00 | $3.21M | $5.97M | $8.91M | $12.09M | $19.89M | $30.20M | $38.56M | $34.02M | $41.40M | $67.42M | $49.55M |
| Long-term debt | — | $1.48M | $9.79M | $0.00 | $9.79M | $7.21M | — | — | — | — | — | — | — |
| Shareholder equity | $-65000.00 | $-1.40M | $21.10M | $103.91M | $88.18M | $59.74M | $59.14M | $37.84M | $10.71M | $21.57M | $-14.44M | $-8.21M | $163.31M |
| Retained earnings | $-66000.00 | $-1.41M | $-13.30M | $-45.50M | $-93.66M | $-149.39M | $-218.74M | $-259.83M | $-334.70M | $-377.17M | $-418.50M | $-441.43M | $-611.26M |
| Accounts receivable | — | — | — | — | $190000.00 | $321000.00 | $1.27M | $10000.00 | $11.18M | $5.36M | $5.83M | $16.25M | $1.69M |
| Inventory | — | — | — | $0.00 | $0.00 | $-321000.00 | — | $-5.55M | — | $-2.59M | $1.00 | $6.10M | — |
| Goodwill | — | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |